Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant Rituximab antibody

MALS verified Reactivity: Human ELISA, LF Host: Mouse Monoclonal unconjugated Recombinant Antibody
Catalog No. ABIN7482277
  • Target See all Rituximab products
    Rituximab
    Antibody Type
    Recombinant Antibody
    Reactivity
    • 1
    • 1
    Human
    Host
    • 4
    • 1
    Mouse
    Clonality
    • 5
    Monoclonal
    Conjugate
    • 2
    • 2
    • 1
    This Rituximab antibody is un-conjugated
    Application
    • 3
    • 2
    • 1
    ELISA, Lateral Flow (LF)
    Purpose
    Anti-Rituximab Antibody (MALS verified)
    Characteristics
    Anti-idiotypic Antibodies
    Grade
    MALS verified
    Immunogen
    Anti-Rituximab Antibody (ABIN7482277) are expressed from human 293 cells (HEK293).
  • Application Notes
    This antibody can be paired with other CD20 antibodies to detect CD20 in sandwich ELISA or LFA assay.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Storage
    -20 °C
  • Target
    Rituximab
    Abstract
    Rituximab Products
    Target Type
    Antibody
    Background
    Rituxan is a genetically engineered chimeric murine/human monoclonal antibody directed against the CD20 antigen found on the surface of normal and malignant B lymphocytes. The antibody is an IgG1 kappa immunoglobulin containing murine light- and heavy-chain variable region sequences and human constant region sequences. Rituximab is composed of two heavy chains of 451 amino acids and two light chains of 213 amino acids, Anti-Rituximab Antibodies (RIB-Y35c) is the monoclonal antibody of Rituximab expressed with human HEK293 cells.
You are here:
Support